These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 19602899

  • 21. Oxidative status and serum PON1 activity in beta-thalassemia minor.
    Selek S, Aslan M, Horoz M, Gur M, Erel O.
    Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
    [Abstract] [Full Text] [Related]

  • 22. Relationship of serum paraoxonase 1 activity and paraoxonase 1 genotype to risk of systemic lupus erythematosus.
    Tripi LM, Manzi S, Chen Q, Kenney M, Shaw P, Kao A, Bontempo F, Kammerer C, Kamboh MI.
    Arthritis Rheum; 2006 Jun; 54(6):1928-39. PubMed ID: 16729301
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The relationship between paraoxonase1-192 polymorphism and activity with coronary artery disease.
    Mohamed RH, Mohamed RH, Karam RA, Abd El-Aziz TA.
    Clin Biochem; 2010 Apr; 43(6):553-8. PubMed ID: 20026099
    [Abstract] [Full Text] [Related]

  • 28. Paraoxonase activity in healthy, diabetic, and hemodialysis patients.
    Gbandjaba NY, Ghalim N, Hassar M, Berrougui H, Labrazi H, Taki H, Saile R, Khalil A.
    Clin Biochem; 2012 Apr; 45(6):470-4. PubMed ID: 22285382
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Paraoxonase 1 phenotype distribution and activity differs in subjects with newly diagnosed Type 2 diabetes (the CODAM Study).
    van den Berg SW, Jansen EH, Kruijshoop M, Beekhof PK, Blaak E, van der Kallen CJ, van Greevenbroek MM, Feskens EJ.
    Diabet Med; 2008 Feb; 25(2):186-93. PubMed ID: 18290860
    [Abstract] [Full Text] [Related]

  • 34. Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients.
    Ozkök E, Aydin M, Babalik E, Ozbek Z, Ince N, Kara I.
    Med Sci Monit; 2008 Oct; 14(10):CR536-42. PubMed ID: 18830194
    [Abstract] [Full Text] [Related]

  • 35. PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients.
    Kotur-Stevuljevic J, Spasic S, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V, Stefanovic A, Vujovic A, Memon L, Kalimanovska-Ostric D.
    Clin Biochem; 2008 Sep; 41(13):1067-73. PubMed ID: 18634772
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Distribution of paraoxonase-1 gene polymorphisms and enzyme activity in a Peruvian population.
    Cataño HC, Cueva JL, Cardenas AM, Izaguirre V, Zavaleta AI, Carranza E, Hernández AF.
    Environ Mol Mutagen; 2006 Dec; 47(9):699-706. PubMed ID: 17078098
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.